The US has exempted Indian pharmaceuticals from tariffs amidst President Trump’s broad tariff imposition, recognizing their ...

Indian pharmaceutical stocks took a hit as Trump's threat of imposing tariffs on pharma imports spooked investors. Despite ...

The Trump administration's decision to exempt tariffs on Indian pharma imports brings relief to a $9 billion-plus US export ...

Billionaire entrepreneur and Cost Plus Drugs co-founder Mark Cuban won't have to raise medicine prices, as Trump’s new ...

US President Trump has exempted India's pharmaceuticals from new reciprocal tariffs, benefiting the major export industry.

US President Donald Trump has imposed a country-level tariff of 27 per cent on exports from India as part of his ‘Liberation ...

The United States is a key market for India’s pharmaceutical exports, with India supplying around 40 per cent of all generic ...

US President says India imposes 52% tariff on American imports and engages in currency manipulation and non-tariff barriers ...

Presently, India imposes 10 percent tariff on Pharma imports from the United States. The US doesn't impose any tariff on ...

India’s pharmaceutical industry has emerged as a notable exception in the recent US tariff announcements. Wanbury announced ...

Pharma stocks plummet as Trump signals steep tariffs on India's drug exports, with concerns over higher costs and profit ...

The US president announced a 27 per cent reciprocal tariff on India, claiming the South Asian country imposes a 52 per cent ...